Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 346,706 | 307,024 | 315,546 | 369,561 | 356,999 |
| Cost of Goods | 43,208 | 39,519 | 44,002 | 35,837 | 40,774 |
| Gross Profit | 303,498 | 267,505 | 271,544 | 333,724 | 316,225 |
| Operating Expenses | 241,546 | 238,347 | 223,907 | 226,798 | 237,119 |
| Operating Income | 62,160 | 29,677 | 47,639 | 107,763 | 79,880 |
| Other Income | 9,442 | 11,991 | 7,877 | 12,487 | 6,171 |
| Pre-tax Income | 71,602 | 41,668 | 55,516 | 120,250 | 86,051 |
| Income Tax | 17,921 | -7,986 | 8,974 | 28,024 | 17,981 |
| Net Income Continuous | 53,681 | 49,654 | 46,542 | 92,226 | 68,070 |
| Minority Interests | 354 | 322 | 471 | 433 | 248 |
| Net Income | $53,327 | $49,332 | $46,071 | $91,793 | $67,822 |
| EPS Basic Total Ops | 0.56 | 0.52 | 0.48 | 0.95 | 0.71 |
| EPS Basic Continuous Ops | 0.56 | 0.52 | 0.49 | 0.96 | 0.71 |
| EPS Diluted Total Ops | 0.55 | 0.50 | 0.48 | 0.94 | 0.70 |
| EPS Diluted Continuous Ops | 0.56 | 0.50 | 0.48 | 0.95 | 0.70 |
| EPS Diluted Before Non-Recurring Items | 0.73 | 0.73 | 0.53 | 1.09 | 0.84 |
| EBITDA(a) | $88,973 | $54,252 | $72,037 | $132,190 | $105,077 |